— Know what they know.
Not Investment Advice

214450.KQ KOE

PharmaResearch Co., Ltd.
1W: -5.1% 1M: -26.1% 3M: -16.5% YTD: -9.1% 1Y: -53.9% 3Y: +135.9% 5Y: +247.8%
₩306,000.00 ($227.55)
-8500.00 (-2.70%)
 
Weekly Expected Move ±3.4%
₩285431 ₩295716 ₩306000 ₩316284 ₩326569
KOE · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 33 · ₩3.18T mcap · 6M float · 2.77% daily turnover

📊 Key Metrics

TTM
₩603B
Revenue
+34.1% YoY
₩186B
Net Income
+46.2% YoY
₩138B
Free Cash Flow
+21.9% YoY
75.3%
Gross Margin
37.2%
Op. Margin
31.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE27.2%
ROA18.3%
ROIC47.2%

Valuation

P/E17.1
P/B4.2
EV/EBITDA17.1

Leverage

Debt/Equity0.29
Current Ratio7.72
Interest Cov.17.4x

Quality Scores

Piotroski F6/9
Altman Z9.58
Beneish M-2.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms